↓ Skip to main content

PLOS

Performance of LBSap Vaccine after Intradermal Challenge with L. infantum and Saliva of Lu. longipalpis: Immunogenicity and Parasitological Evaluation

Overview of attention for article published in PLOS ONE, November 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
81 Mendeley
Title
Performance of LBSap Vaccine after Intradermal Challenge with L. infantum and Saliva of Lu. longipalpis: Immunogenicity and Parasitological Evaluation
Published in
PLOS ONE, November 2012
DOI 10.1371/journal.pone.0049780
Pubmed ID
Authors

Bruno Mendes Roatt, Rodrigo Dian de Oliveira Aguiar-Soares, Juliana Vitoriano-Souza, Wendel Coura-Vital, Samuel Leôncio Braga, Rodrigo Corrêa-Oliveira, Olindo Assis Martins-Filho, Andréa Teixeira-Carvalho, Marta de Lana, Nelder Figueiredo Gontijo, Marcos José Marques, Rodolfo Cordeiro Giunchetti, Alexandre Barbosa Reis

Abstract

In the last decade, the search for new vaccines against canine visceral leishmaniasis has intensified. However, the pattern related to immune protection during long periods after experimental infection in vaccine trials is still not fully understood. Herein, we investigated the immunogenicity and parasitological levels after intradermal challenge with Leishmania infantum plus salivary gland extract in dogs immunized with a vaccine composed of L. braziliensis antigens plus saponin as an adjuvant (LBSap vaccine). The LBSap vaccine elicited higher levels of total anti-Leishmania IgG as well as both IgG1 and IgG2. Furthermore, dogs vaccinated had increased levels of lymphocytes, particularly circulating B cells (CD21(+)) and both CD4(+) and CD8(+) T lymphocytes. LBSap also elicited an intense in vitro cell proliferation associated with higher levels of CD4(+) T lymphocytes specific for vaccine soluble antigen and soluble lysate of L. infantum antigen even 885 days after experimental challenge. Furthermore, LBSap vaccinated dogs presented high IFN-γ and low IL-10 and TGF-β1 expression in spleen with significant reduction of parasite load in this tissue. Overall, our results validate the potential of LBSap vaccine to protect against L. infantum experimental infection and strongly support further evaluation of efficiency of LBSap against CVL in natural infection conditions.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 81 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 2%
India 1 1%
France 1 1%
Brazil 1 1%
Unknown 76 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 22%
Student > Master 16 20%
Student > Ph. D. Student 9 11%
Student > Bachelor 8 10%
Student > Postgraduate 3 4%
Other 8 10%
Unknown 19 23%
Readers by discipline Count As %
Agricultural and Biological Sciences 22 27%
Veterinary Science and Veterinary Medicine 10 12%
Immunology and Microbiology 7 9%
Biochemistry, Genetics and Molecular Biology 6 7%
Medicine and Dentistry 5 6%
Other 9 11%
Unknown 22 27%